Publication Results (439)

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »

• Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study

  Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G. PLoS Med. 2014; 11(2):e1001599. Epub 2014 Feb 4.

• A population-based description of atrial fibrillation in the emergency department, 2002 to 2010

  Atzema CL, Austin PC, Miller E, Chong AS, Yun L, Dorian P. Ann Emerg Med. 2013; 62(6):570-7.e7. Epub 2013 Jun 27.

• Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study

  Shah BR, Victor JC, Chiu M, Tu JV, Anand SS, Austin PC, Manuel DG, Hux JE. Diabetes Care. 2013; 36(9):2670-6. Epub 2013 May 1.

• Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions

  Fleet JL, Shariff SZ, Bailey DG, Gandhi S, Juurlink DN, Nash DM, Mamdani M, Gomes T, Patel AM, Garg AX. BMJ Open. 2013; 3:e002857. Epub 2013 Jul 13.

• Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada

  Kitchlu A, Clemens K, Gomes T, Hackam DG, Juurlink DN, Mamdani M, Manno M, Oliver MJ, Quinn RR, Suri RS, Wald R, Yan AT, Garg AX. Nephrol Dial Transplant. 2012; 27(4):1591-8. Epub 2011 Aug 26.

• The CANHEART health index: a tool for monitoring the cardiovascular health of the Canadian population

  Maclagan LC, Park J, Sanmartin C, Mathur KR, Roth D, Manuel DG, Gershon A, Booth GL, Bhatia S, Atzema CL, Tu JV. CMAJ. 2014; 186(3):180-7. Epub 2013 Dec 23.

• Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries

  McGettigan P, Henry D. PLoS Med. 2013; 10(2):e1001388. Epub 2013 Feb 12.

• Regional variations in ambulatory care and incidence of cardiovascular events

  Tu JV, Chu A, Maclagan L, Austin PC, Johnston S, Ko DT, Cheung I, Atzema CL, Booth GL, Bhatia RS, Lee DS, Jackevicius CA, Kapral MK, Tu K, Wijeysundera HC, Alter DA, Udell JA, Manuel DG, Mondal P, Hogg W; for the Cardiovascular Health in Ambulatory Care Research Team (CANHEART). CMAJ. 2017; 189(13):E494-501.

• Predictors of obtaining follow-up care in the province of Ontario, Canada, following a new diagnosis of atrial fibrillation, heart failure, and hypertension in the emergency department

  Atzema CL, Yu B, Ivers NM, Rochon PA, Lee DS, Schull MJ, Austin PC. CJEM. 2018; 20(3):377-91. Epub 2017 Aug 14.

• Long-term risk of a seizure disorder after eclampsia

  Nerenberg KA, Park AL, Vigod SN, Saposnik G, Berger H, Hladunewich MA, Gandhi S, Silversides CK, Ray JG. Obstet Gynecol. 2017; 130(6):1327-33. Epub 2017 Nov 3.

• A clinical decision instrument to predict 30-day death and cardiovascular hospitalizations after an emergency department visit for atrial fibrillation: The Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) study

  Atzema CL, Dorian P, Fang J, Tu JV, Lee DS, Chong AS, Austin PC. Am Heart J. 2018; 203:85-92. Epub 2018 Jun 12.

• Association between statin use and cardiovascular events after carotid artery revascularization

  Hussain MA, Saposnik G, Raju S, Salata K, Mamdani M, Tu JV, Bhatt DL, Verma S, Al-Omran M. J Am Heart Assoc. 2018; 7(16):e009745. Epub 2018 Aug 8.

• Long term outcomes of cluster randomized trial to improve cardiovascular health at population level: the Cardiovascular Health Awareness Program (CHAP)

  Dahrouge S, Kaczorowski J, Dolovich L, Paterson M, Thabane L, Tu K, Younger J, Chambers L. PLoS One. 2018; 13(9):e0201802. Epub 2018 Sep 6.

• Intravitreal anti-vascular endothelial growth factor treatment and the risk of thromboembolism

  Schlenker MB, Thiruchelvam D, Redelmeier DA. Am J Opthalmol. 2015; 160(3):569-580.e5. Epub 2015 Jun 23.

• Risk of cardiovascular events and mortality among a population-based cohort of immigrants and long-term residents with diabetes: are all immigrants healthier and if so, for how long?

  Okrainec K, Bell CM, Hollands S, Booth GL. Am Heart J. 2015; 170(1):123-32. Epub 2015 Apr 18.

• A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario

  Kendall CE, Wong J, Taljaard M, Glazier RH, Hogg W, Younger J, Manuel DG. BMC Public Health. 2014; 14:161.

• All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study

  Hawker GA, Croxford R, Bierman AS, Harvey PJ, Ravi B, Stanaitis I, Lipscombe, L. PLoS One. 2014; 9(3):e91286.

• Disability-free survival after coronary artery bypass grafting in women and men with heart failure

  Sun LY, Tu JV, Lee DS, Beanlands RS, Ruel M, Austin PC, Eddeen AB, Liu PP. Open Heart. 2018; 5:e000911. Epub 2018 Nov 5.

• Cardiovascular outcomes and all-cause mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease (overlap syndrome)

  Kendzerska T, Leung RS, Aaron SD, Ayas N, Sandoz JS, Gershon AS; Canadian Respiratory Research Network. Ann Am Thorac Soc. 2019; 16(1):71-81. Epub 2018 Oct 29.

• Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013

  Gong IY, Yan AT, Ko DT, Earle CC, Cheung WY, Peacock S, Hall M, Gale CP, Chan KKW. Cancer. 2018; 124(6):1269-78. Epub 2017 Dec 6.

• Effect of air quality alerts on human health: a regression discontinuity analysis in Toronto, Canada

  Chen H, Li Q, Kaufman JS, Wang J, Copes R, Su Y, Benmarhnia T. Lancet Planet Health. 2018; 2(1):e19-26. Epub 2018 Jan 8.

• The Canadian experience using the expanded criteria donor classification for allocating deceased donor kidneys for transplantation

  Young A, Dixon SN, Knoll GA, Garg AX, Lok CE, Lam NN, Kim SJ. Can J Kidney Health Dis. 2016; 3:15.

• Trends in chronic disease incidence rates from the Canadian Chronic Disease Surveillance System

  Hamm NC, Pelletier L, Ellison J, Tennenhouse L, Reimer K, Paterson MJ, Puchtinger R, Bartholomew S, Phillips KAM, Lix LM. Health Promot Chronic Dis Prev Can. 2019; 39(6-7):216-24. Epub 2019 Jun 1. DOI: 10.24095/hpcdp.39.6/7.02.

• Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study

  Abdel-Qadir H, Thavendiranathan P, Austin PC, Lee DS, Amir E, Tu JV, Fung K, Anderson GM. Eur. Heart J. 2019; 40(48):3913-20. Epub 2019 Jul 18. DOI: 10.1093/eurheartj/ehz460.

• Real-world risk of cardiovascular outcomes associated with hypertriglyceridemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies

  Lawler PR, Kotrri G, Koh M, Goodman SG, Farkouh ME, Lee DS, Austin PC, Udell JA, Ko DT. Eur Heart J. 2020; 41(1):86-94. Epub 2019 Nov 16. DOI: https://doi.org/10.1093/eurheartj/ehz767

• Smoking, drinking, diet and physical activity—modifiable lifestyle risk factors and their associations with age to first chronic disease

  Ng R, Sutradhar R, Zhan Y, Wodchis WP, Rosella L. Int J Epidemiol. 2020; 49(1):113-30. Epub 2019 Apr 26. DOI: https://doi.org/10.1093/ije/dyz078

• Off-pump versus on-pump coronary artery bypass grafting in moderate renal failure

  Rocha RV, Yanagawa B, Hussain MA, Tu JV, Fang J, Ouzounian M, Cusimano RJ. J Thorac Cardiovasc Surg. 2020; 159(4):1297-304.e2. Epub 2019 Jun 18. DOI: https://doi.org/10.1016/j.jtcvs.2019.03.142.

• Chronic Disease Population Risk Tool (CDPoRT): a study protocol for a prediction model that assesses population-based chronic disease incidence

  Ng R, Sutradhar R, Wodchis WP, Rosella LC. Diagn Progn Res. 2018; 2:19. Epub 2018 Oct 1.

• Association between allopurinol and cardiovascular outcomes and all-cause mortality in diabetes: a retrospective, population-based cohort study

  Weisman A, Tomlinson GA, Lipscombe LL, Perkins BA, Hawker GA. Diabetes Obes Metab. 2019; 21(6):1322-9. Epub 2019 Feb 8.

• Predictors of cumulative health care costs associated with transcatheter aortic valve replacement in severe aortic stenosis

  Tam DY, Qiu F, Elbaz-Greener G, Henning KA, Humphries KH, Lauck SB, Webb J, Fremes SE, Wijeysundera HC. Can J Cardiol. 2020; 36(8):1244-51. Epub 2019 Dec 17. DOI: https://doi.org/10.1016/j.cjca.2019.12.011

• Long-term survival after surgical or percutaneous revascularization in patients with diabetes and multivessel coronary disease

  Tam DY, Dharma C, Rocha R, Farkouh ME, Abdel-Qadir H, Sun LY, Wijeysundera HC, Austin PC, Udell JA, Gaudino M, Fremes SE, Lee DS. J Am Coll Cardiol. 2020; 76(10):1153-64. Epub 2020 Sep 1. DOI: https://doi.org/10.1016/j.jacc.2020.06.052

• Low-density lipoprotein cholesterol and adverse cardiovascular events after percutaneous coronary intervention

  Sud M, Han L, Ko M, Abdel-Qadir H, Austin PC, Farkouh ME, Godoy LC, Lawler PR, Udell JA, Wijeysundera HC, Ko DT. J Am Coll Cardiol. 2020; 76(12):1440-50. Epub 2020 Sep 14. DOI: https://doi.org/10.1016/j.jacc.2020.07.033

• Comparative effectiveness of generic atorvastatin and Lipitor® in patients hospitalized with an acute coronary syndrome

  Jackevicius CA, Tu JV, Krumholz HM; Austin, PC, Ross JS, Stukel TA, Koh M, Chong A, Ko DT. J Am Heart Assoc. 2016; 5:e003350.

• Clinical outcomes of Plavix and generic clopidogrel for patients hospitalized with an acute coronary syndrome

  Ko DT, Krumholz HM, Tu JV, Austin PC, Stukel TA, Koh M, Chong A, de Melo JF, Jackevicius CA. Circ Cardiovasc Qual Outcomes. 2018; 11(3):e004194. Epub 2018 Mar 13.

• Long-term follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)

  Arbel Y, Ko DT, Yan AT, Cantor WJ, Bagai A, Koh M, Eberg M, Tan M, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Morrison LJ, Langer A, Dzavik V, Mehta SR, Goodman SG; TRANSFER-AMI Trial Investigators. Can J Cardiol. 2018; 34(6):736-43. Epub 2018 Feb 10.

• Population trends in all‐cause mortality and cause specific–death with incident atrial fibrillation

  Singh SM, Abdel-Qadir H, Pang A, Fang J, Koh M, Dorian P, Wijeysundera HC, Ko DT. J Am Heart Assoc. 2020; 9(19):e016810. Epub 2020 Sep 13. DOI: https://doi.org/10.1161/JAHA.120.016810

• Outcomes after endovascular versus open thoracoabdominal aortic aneurysm repair: a population-based study

  Rocha RV, Lindsay TF, Austin PC, Al-Omran M, Forbes TL, Lee DS, Ouzounian M. J Thorac Cardiovasc Surg. 2021; 161(2):516-27.e6. Epub 2019 Nov 25. DOI: https://doi.org/10.1016/j.jtcvs.2019.09.148

• Cardiac rehabilitation is associated with improved long-term outcomes after coronary artery bypass grafting

  Karkhanis R, Wijeysundera HC, Tam DY, Yu B, Kiss A, Fremes SE. CJC Open. 2021; 3(2):167-75. Epub 2020 Oct 12. DOI: https://doi.org/10.1016/j.cjco.2020.10.004

• Outcomes of abdominal aortic aneurysm repair among patients with rheumatoid arthritis

  Salata K, Almaghlouth I, Hussain MA, de Mestral C, Greco E, Aljabri BA, Mamdani M, Forbes TL, Verma S, Al-Omran M. J Vasc Surg. 2021; 73(4):1261-8.e5. Epub 2020 Sep 17. DOI: https://doi.org/10.1016/j.jvs.2020.08.134

• Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study

  Doumouras AG, Wong JA, Paterson JM, Lee Y, Sivapathasundaram B, Tarride J, Thabane L, Hong D, Yusuf S, Anvari M. Circulation. 2021; 143(15):1468-80. Epub Apr 5. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.052386

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »